HK.3-JN.1 SARS-CoV-2 mRNA Vaccine

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameHK.3-JN.1 SARS-CoV-2 mRNA Vaccine
Drug Alias NameHK.3-JN.1新冠mRNA疫苗HK.3-JN.1新型冠状病毒mRNA疫苗
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesChongqing Zhifei Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Zhifei Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A